Cited by 567

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

Open access

Juhan-Vague, I., Alessi, M. C., Vague, P.·1991·Diabetologia

DOI 10.1007/bf00403280

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/bf00403280

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.
Larsson, B., Svärdsudd, K., Welin, L., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1984) · BMJ · doi:10.1136/bmj.288.6428.1401 · Cited by 1,934
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
The Degree of Masculine Differentiation of Obesities
VAGUE, J. (1956) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/4.1.20 · Cited by 1,410
Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
Hamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
Thrombosis as a factor in the pathogenesis of coronary atherosclerosis
Duguid, J. B. (1946) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700580207 · Cited by 796
Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland
Pyörälä, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.131 · Cited by 768
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., & Rosselin, G. (1980) · Diabetologia · doi:10.1007/bf00275270 · Cited by 747
Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations
Welborn, T. A., & Wearne, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.154 · Cited by 735
Reappraisal of the role of insulin in hypertriglyceridemia
Olefsky, J. M., Farquhar, J. W., & Reaven, G. M. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90006-0 · Cited by 482
Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
Vague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M. C., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Self-citation
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
Loskutoff, D. J., van Mourik, J. A., Erickson, L. A., & Lawrence, D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.10.2956 · Cited by 399
Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis
Juhan-Vague, I., Valadier, J., Alessi, M. C., Aillaud, M. F., Ansaldi, J., Philip-Joet, C., Holvoet, P., Serradimigni, A., & Collen, D. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651064 · Cited by 362
Self-citation
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1
Landin, K., Stigendal, L., Eriksson, E., Krotkiewski, M., Risberg, B., Tengborn, L., & Smith, U. (1990) · Metabolism · doi:10.1016/0026-0495(90)90164-8 · Cited by 342
INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES
Temple, R., Luzio, S., Schneider, A., Carrington, C., Owens, D., Sobey, W., & Nicholas Hales, C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91306-8 · Cited by 337
Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease
LANDIN, K., TENGBORN, L., & SMITH, U. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00157.x · Cited by 308
Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
Paramo, J. A., Colucci, M., Collen, D., & van de Werf, F. (1985) · BMJ · doi:10.1136/bmj.291.6495.573 · Cited by 302
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
Stiko-Rahm, A., Wiman, B., Hamsten, A., & Nilsson, J. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.6.1067 · Cited by 298
Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma Insulin
Juhan-Vague, I., Roul, C., Alessi, M. C., Ardissone, J. P., Heim, M., & Vague, P. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646598 · Cited by 289
Self-citation
Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2
Alessi, M. C., Juhan-Vague, I., Kooistra, T., Declerck, P. J., & Collen, D. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646997 · Cited by 289
Self-citation
HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY
Simpson, H. C. R., Meade, T. W., Stirling, Y., Mann, J. I., Chakrabarti, R., & Woolf, L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91849-4 · Cited by 287
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
Auwerx, J., Bouillon, R., Collen, D., & Geboers, J. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.68 · Cited by 276
Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance
Ward, W. K., LaCava, E. C., Paquette, T. L., Beard, J. C., Wallum, B. J., & Porte, D. (1987) · Diabetologia · doi:10.1007/bf00296991 · Cited by 275
INSULIN AND ATHEROMA
Stout, R. W., & Vallance-Owen, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91711-5 · Cited by 249
Demonstration of a Relationship Between Level of Physical Training and Insulin-stimulated Glucose Utilization in Normal Humans
Rosenthal, M., Haskell, W. L., Solomon, R., Widstrom, A., & Reaven, G. M. (1983) · Diabetes · doi:10.2337/diab.32.5.408 · Cited by 247
Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations
Mehta, J., Mehta, P., Lawson, D., & Saldeen, T. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80373-x · Cited by 239
Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease
OOLOFESSON, B. O., DAHLÈN, G., & NILSSON, T. K. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059384 · Cited by 224
Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
Juhan-Vague, I., Vague, P., Alessi, M., Badier, C., Valadier, J., Aillaud, M.-F., & Atlan, C. (1987) · PubMed · Cited by 218
Self-citation
Mechanism of metformin action in non-insulin-dependent diabetes
Jackson, R. A., Hawa, M. I., Jaspan, J. B., Sim, B. M., DiSilvio, L., Featherbe, D., & Kurtz, A. B. (1987) · Diabetes · doi:10.2337/diab.36.5.632 · Cited by 202
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
Juhan-Vague, I., Alessi, M. C., Joly, P., Thirion, X., Vague, P., Declerck, P. J., Serradimigni, A., & Collen, D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.3.362 · Cited by 201
Self-citation
The relationships of concentrations of insulin, intact proinsulin and 32–33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects
Nagi, D. K., Hendra, T. J., Ryle, A. J., Cooper, T. M., Temple, R. C., Clark, P. M. S., Schneider, A. E., Hales, C. N., & Yudkin, J. S. (1990) · Diabetologia · doi:10.1007/bf00404140 · Cited by 198
Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
Aznar, J., Estelles, A., Tormo, G., Sapena, P., Tormo, V, Blanch, S., & Espana, F. (1988) · Heart · doi:10.1136/hrt.59.5.535 · Cited by 188
Daytime Fluctuations in Blood of Tissue-Type Plasminogen Activator (t-PA) and Its Fast-Acting Inhibitor (PAI-1)
Kluft, C., Jie, A. F. H., Rijken, D. C., & Verheijen, J. H. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642781 · Cited by 184
Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes
Kooistra, T., Bosma, P. J., Töns, H. A. M., van den Berg, A. P., Meyer, P., & Princen, H. M. G. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646891 · Cited by 182
Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus
Yoshioka, N., Kuzuya, T., Matsuda, A., Taniguchi, M., & Iwamoto, Y. (1988) · Diabetologia · doi:10.1007/bf02341503 · Cited by 175
Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects
Vague, P., Juhan-Vague, I., Alessi, M. C., Badier, C., & Valadier, J. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651126 · Cited by 165
Self-citation
Blood Fibrinolytic Activity in Diabetes Mellitus and Its Bearing on Ischaemic Heart Disease and Obesity
Fearnley, G. R., Chakrabarti, R., & Avis, P. R. D. (1963) · BMJ · doi:10.1136/bmj.1.5335.921 · Cited by 135
Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a North Swedish population
BIRGITTASUNDELL, I., Nilsson, T. K., Hallmans, G., Hellsten, G., & Dahlén, G. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90062-2 · Cited by 129
Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.
Sprengers, E. D., Princen, H. M., Kooistra, T., & van Hinsbergh, V. W. M. (1985) · PubMed · Cited by 128
Circadian Fluctuations of Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma of Patients with Unstable Coronary Artery Disease and Acute Myocardial Infarction
Huber, K., Rość, D., Resch, I., Schuster, E., Glogar, D. H., Kaindl, F., & Binder, B. R. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646974 · Cited by 128
Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women
Vague, P., Juhan-Vague, I., Chabert, V., Alessi, M., & Atlan, C. (1989) · Metabolism · doi:10.1016/0026-0495(89)90241-2 · Cited by 126
Self-citation
Impaired fibrinolysis in coronary artery disease
Francis, R. B., Kawanishi, D. T., Baruch, T., Mahrer, P. R., Rahimtoola, S. H., & Feinstein, D. I. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90878-2 · Cited by 113
Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction
Almér, L., & Öhlin, H. (1987) · Thrombosis Research · doi:10.1016/0049-3848(87)90147-2 · Cited by 110
Dietary regulation of fibrinolytic factors
Mehrabian, M., PETER, J., BARNARD, R., & Lusis, A. J. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90004-3 · Cited by 108
Atherosclerosis and the coagulation system
Thompson, W. D., & Smith, E. B. (1989) · The Journal of Pathology · doi:10.1002/path.1711590203 · Cited by 92
Increased blood fibrinolytic activity after physical exercise: Comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program
Speiser, W., Langer, W., Pschaick, A., Selmayr, E., Ibe, B., Nowacki, P. E., & MÜLLER‐BERGHAUS, G. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90119-3 · Cited by 90
FIBRINOLYSIS IN OBESITY
Ogston, D., & McAndrew, G. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91042-6 · Cited by 89
Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: A cross-sectional study in Norsjö, Sweden
Sundell, I. B., Nilsson, T. K., Rånby, M., Hallmans, G., & Hellsten, G. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90067-x · Cited by 83
The extrinsic fibrinolytic system in survivors of myocardial infarction
Nilsson, T., & Johnson, O. (1987) · Thrombosis Research · doi:10.1016/0049-3848(87)90428-2 · Cited by 83
Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries
Verheugt, F. W. A., ten Cate, J. W., Sturk, A., Imandt, L. M. F. M., Verhorst, P. M. J., van Eenige, M. J., Verwey, W., & Roos, J. P. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90851-4 · Cited by 81
Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions
Bini, A., Fenoglio, J. J., Sobel, J., OWEN, J. D., Fejgl, M., & Kaplan, K. (1987) · Blood · doi:10.1182/blood.v69.4.1038.1038 · Cited by 78
Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
Oseroff, A., Krishnamurti, C., Hassett, A., Tang, D. B., & Alving, B. M. (1989) · PubMed · Cited by 73
Short-Term Infusions of Insulin, Triacylglycerol and Glucose do not Cause Acute Increases in Plasminogen Activator Inhibitor-1 Concentrations in Man
Grant, P. J., Kruithof, E. K. O., Felley, C. P., Felber, J. P., & Bachmann, F. (1990) · Clinical Science · doi:10.1042/cs0790513 · Cited by 72
Low vascular fibrinolytic activity in obesity
Almér, L., & Janzon, L. (1975) · Thrombosis Research · doi:10.1016/0049-3848(75)90021-3 · Cited by 69
Fibrinolysis and body build
Grace, C. S., & Goldrick, R. B. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80028-6 · Cited by 66
Reduction of elevated plasminogen activator inhibitor levels during modest weight loss
Sundell, I. B., Dahlgren, S. E., Rånby, M., Lundin, E., Stenling, R., & Nilsson, T. (1989) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(89)90028-3 · Cited by 58
Hyperlipoproteinaemia and Reduced Fibrinolytic Activity in Healthy Coronary High‐Risk Men
Andersen, P., Arnesen, H., & Hjermann, I. (1981) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1981.tb11576.x · Cited by 57
Effect of weight loss on glucose disposal in obese and obese diabetic patients.
Golay, A., Jp, F., Dusmet, M., Espinosa-Gómez, F. C., Curchod, B., & Jéquier, E. (1985) · PubMed · Cited by 55
FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE
Chakrabarti, R., Hocking, E., & Fearnley, G. R. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92383-4 · Cited by 52
Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction
Estellés, A., Aznar, J., Tormo, G., Sapena, P., Tormo, V., & España, F. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90437-4 · Cited by 51
RELATIONSHIP BETWEEN BLOOD FIBRINOLYTIC ACTIVITY AND BODY FATNESS
Shaw, D. A., & Macnaughton, D. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91381-3 · Cited by 42
Defective Insulin Receptor Function in Down-Regulated HepG2 Cells*
Williams, J. F., & Olefsky, J. M. (1990) · Endocrinology · doi:10.1210/endo-127-4-1706 · Cited by 40
Dual effect of metformin in cultured rat hepatocytes: Potentiation of insulin action and prevention of insulin-induced resistance
Melin, B., Cherqui, G., Eggelpoël, M.-J. B.-V., Caron, M., Lascols, O., Capeau, J., & Picard, J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90171-8 · Cited by 38
Acute exogenous hyperinsulinaemia does not result in elevation of plasma plasminogen activator inhibitor-1 (PAI-1) in humans
van Loon, B. J. P., de Bart, A. C. W., Radder, J. K., Frölich, M., Kluft, C., & Meinders, A. E. (1990) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(90)90373-r · Cited by 37
Hypofibrinolysis and insulin-resistance.
Juhan-Vague, I., & Vague, P. (1991) · PubMed · Cited by 37
Self-citation
Impact of physical training on plasminogen activator inhibitor activity in sedentary men
Gris, J., Schved, J., Aguilar‐Martinez, P., Arnaud, A., & Sanchez, N. (1990) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(90)90375-t · Cited by 30
Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients
Gram, J., Jespersen, J., & Kold, A. (1988) · Metabolism · doi:10.1016/0026-0495(88)90150-3 · Cited by 28
General practitioner and long term care of patients with a spinal injury.
Mulroy, R. (1985) · BMJ · doi:10.1136/bmj.291.6495.575 · Cited by 27
Reduced fibrinolytic response in obese children: Association with high baseline activity of the fast acting plasminogen activator inhibitor (PAI-1)
Legnani, C., Maccaferri, M., Tonini, P., Cassio, A., CACCIARI, E., & COCCHERI, S. (1988) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(88)90015-x · Cited by 21
Untitled work
(1987) · PubMed · Cited by 20
Body composition and weight reduction in relation to antigen and activity of plasminogen activitor inhibitor (PAI-1) in overweight individuals
Huisveld, I. A., Leenen, R. C. A., Kooy, K. V. D., Hospers, J. E. H., Seidell, J. C., Deurenberg, P., Koppeschaar, H. P. F., Mosterd, W. L., & Bouma, B. N. (1990) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(90)90369-u · Cited by 19

Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525
PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences
Alessi, M.-C., & Juhan-Vague, I. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000242905.41404.68 · Cited by 390
Self-citation
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Juhan-Vague, I., Alessi, M.-C., Mavri, A., & Morange, P. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00279.x · Cited by 371
Self-citation
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Alessi, M. C., Bastelica, D., Morange, P., Berthet, B., Leduc, I., Verdier, M., Geel, O., & Juhan-Vague, I. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1374 · Cited by 344
Self-citation

See all 567

Authors: Juhan-Vague, I., Alessi, M. C., & Vague, P.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 1991-07
Volume: 34
Issue: 7
Pages: 457-462
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/bf00403280
OpenAlex: W2091066652
Cited by: 567
References: 71
FWCI: 15.07
Type: journal article
Language: en
Open access: bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources